Browsing by Subject "Candida"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Open Access
    Case report: SARS-CoV-2 infection-Are we dedeemed? A report of Candida spondylodiscitis as a late complication
    (Frontiers Media, 2021-11-26) Moreno-Gómez, Luis Miguel; Esteban-Sinovas, Olga; García Pérez, Daniel; García-Posadas, Guillermo; Delgado-Fernández, Juan; Paredes, Igor; Farmacología; Facultad de Farmacia
    Background: We describe a case of candida spondylodiscitis secondary to coronavirus disease (COVID-19). Case report: A 47-year-old man diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) required prolonged admission to the intensive care unit (ICU). Four months later, he was diagnosed with thoracic candida spondylodiscitis. Medical management was insufficient, so he eventually underwent surgery. Discussions: Fungal infections seem to be more likely in patients with COVID-19, but it is unknown whether they are directly attributed to COVID-19 or other surrounding factors. Regardless of the answer, the diagnosis is complicated, and the mortality rate is high. Lessons: COVID-19 is posing a challenge to the society, and new and unexpected diseases that had once disappeared have risen again. It is our duty to suspect them and to treat them in the most effective way possible.
  • Thumbnail Image
    Publication
    Restricted
    Use of antifungal agents for oral candidiasis: results of a national survey
    (Wiley, 2010-02-01) Martínez Beneyto, Yolanda; López-Jornet, Pia; Velandrino-Nicolás, A.; Jornet García, V.; Dermatología, Estomatología, Radiología y Medicina Física
    Abstract: Background: Candida albicans is an opportunistic agent that colonizes the oral mucosa. Objectives: To determine the attitude of Spanish dentists toward the oral treatment of candidiasis. Method: Between May and November 2006, a questionnaire was circulated to a random selection of 1134 dentists obtained from the General Dental Council’s main list. The survey consisted of a block of socio-demographic items followed by another block related to the diagnosis and treatment of oral candidiasis. Replies to the questionnaire were received from 840 (74%) dentists. Results: 50.4% of respondents were men, and 48.1% were female with a mean age of 38 and 12.2 years of professional experience. Miconazole was the most popular choice of antifungal agent prescribed (59.3%), followed by nystatin (57.7%) for topical use. Systemic antifungal agents were used by 30.20% of dentists, with a strong association between their use and the number of years in practice, gender and professional qualifications (P < 0.005). Conclusion: Most Spanish dentists make clinical diagnosis and treat oral infections by C. albicans themselves with topical drugs (miconazole and nystatin) as a first choice. Systemic treatments are more commonly chosen by male dentists with long professional experience, especially by stomatologists.